Report Detail
Global Non-Invasive Blood Glucose Monitoring Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4685900 |
- 12 March, 2026 |
- Global |
- 114 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Non-Invasive Blood Glucose Monitoring Devices market size was valued at US$ 11750 million in 2025 and is forecast to a readjusted size of US$ 27765 million by 2032 with a CAGR of 13.2% during review period.
Non-Invasive Blood Glucose Monitoring Devices refer to glucose monitoring systems that enable people with diabetes to track glucose without routine fingerstick blood sampling, avoiding the need to draw blood and reducing finger pain and trauma in daily use. They typically combine a replaceable disposable sensing component with durable hardware and software that collect, process, display, and store glucose readings and trends, and may provide alerts and decision support to help users and clinicians manage therapy and prevent acute and chronic complications. These devices are designed for frequent or continuous monitoring in real world settings, with connectivity and data services that support long term tracking, sharing, and integration into care pathways. Non-Invasive Blood Glucose Monitoring Devices typically cost tens to hundreds of dollars, with industry gross margins generally between 40% and 60%.
Upstream, the supply chain starts with specialized inputs for the disposable sensing component, including biosensing chemistry and enzymes or alternative sensing materials, electrode and substrate materials, membranes, adhesives and skin contact materials, microelectronics, batteries, and sterile packaging, alongside software and cybersecurity capabilities that support data capture and decision support. Core manufacturing typically involves high precision sensor fabrication and calibration, assembly of the wearable form factor, production of durable components such as transmitters, readers, or charging accessories, and development of mobile apps and cloud platforms, with quality systems, traceability, and regulatory compliance embedded throughout and with contract manufacturers often supporting scale up, packaging, and some electronics assembly. Downstream, products reach users through a mix of prescription led clinical initiation and training, pharmacy and medical device distribution for replenishment of disposable sensors, direct to consumer channels where allowed, and institutional procurement pathways where payers and public health systems use formularies or tenders to control access and pricing. Beyond the physical channel, the downstream value chain increasingly includes patient onboarding and education, customer support and replacement logistics, data sharing with clinicians, integration into telehealth and chronic care programs, and partnerships with insulin delivery, electronic medical record, and digital therapeutics ecosystems that can meaningfully influence adherence, switching, and lifetime value.
Non-Invasive Blood Glucose Monitoring Devices are shifting glucose management from a periodic self test behavior to a continuous, data driven care loop, and this is where the category’s long term value is being created. The competition is increasingly ecosystem based rather than hardware based, because sustained adoption depends on comfort and wear experience, sensor performance stability, alert quality, app usability, interoperability with insulin delivery and clinical systems, and the ability to prove real world outcome and cost benefits to payers. The market is likely to keep bifurcating into premium platforms that win on accuracy, reliability, and workflow integration versus value platforms that win on access and scale, with the biggest strategic upside coming from expanding beyond intensively managed patients into broader populations, and from building service layers such as remote monitoring, coaching, and population health programs. At the same time, pricing and reimbursement pressure, tender dynamics in some markets, and regulatory scrutiny of marketing claims will keep raising the bar, meaning new entrants need not only sensor technology but also manufacturing scale, clinical evidence generation, and channel access to compete sustainably.
This report is a detailed and comprehensive analysis for global Non-Invasive Blood Glucose Monitoring Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-Invasive Blood Glucose Monitoring Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Non-Invasive Blood Glucose Monitoring Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Non-Invasive Blood Glucose Monitoring Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Non-Invasive Blood Glucose Monitoring Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Invasive Blood Glucose Monitoring Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Invasive Blood Glucose Monitoring Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Medtronic, Dexcom, I-SENS, Senseonics, Yuwell, Sinocare, MicroTech Medical, POCTech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Non-Invasive Blood Glucose Monitoring Devices market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Replaceable Type
Long-term Retention Type
Market segment by Continuity
Single-Point Monitoring
Continuous Monitoring
Market segment by Intelligence
Basic Type
Intelligent Type
Market segment by Application
Hospital
Home Use
Others
Major players covered
Roche
Abbott
Medtronic
Dexcom
I-SENS
Senseonics
Yuwell
Sinocare
MicroTech Medical
POCTech
Medtrum Technologies
SIBIONICS
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-Invasive Blood Glucose Monitoring Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-Invasive Blood Glucose Monitoring Devices, with price, sales quantity, revenue, and global market share of Non-Invasive Blood Glucose Monitoring Devices from 2021 to 2026.
Chapter 3, the Non-Invasive Blood Glucose Monitoring Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-Invasive Blood Glucose Monitoring Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Non-Invasive Blood Glucose Monitoring Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-Invasive Blood Glucose Monitoring Devices.
Chapter 14 and 15, to describe Non-Invasive Blood Glucose Monitoring Devices sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Non-Invasive Blood Glucose Monitoring Devices Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Replaceable Type
- 1.3.3 Long-term Retention Type
- 1.4 Market Analysis by Continuity
- 1.4.1 Overview: Global Non-Invasive Blood Glucose Monitoring Devices Consumption Value by Continuity: 2021 Versus 2025 Versus 2032
- 1.4.2 Single-Point Monitoring
- 1.4.3 Continuous Monitoring
- 1.5 Market Analysis by Intelligence
- 1.5.1 Overview: Global Non-Invasive Blood Glucose Monitoring Devices Consumption Value by Intelligence: 2021 Versus 2025 Versus 2032
- 1.5.2 Basic Type
- 1.5.3 Intelligent Type
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Non-Invasive Blood Glucose Monitoring Devices Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Hospital
- 1.6.3 Home Use
- 1.6.4 Others
- 1.7 Global Non-Invasive Blood Glucose Monitoring Devices Market Size & Forecast
- 1.7.1 Global Non-Invasive Blood Glucose Monitoring Devices Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales Quantity (2021-2032)
- 1.7.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche Non-Invasive Blood Glucose Monitoring Devices Product and Services
- 2.1.4 Roche Non-Invasive Blood Glucose Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Roche Recent Developments/Updates
- 2.2 Abbott
- 2.2.1 Abbott Details
- 2.2.2 Abbott Major Business
- 2.2.3 Abbott Non-Invasive Blood Glucose Monitoring Devices Product and Services
- 2.2.4 Abbott Non-Invasive Blood Glucose Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Abbott Recent Developments/Updates
- 2.3 Medtronic
- 2.3.1 Medtronic Details
- 2.3.2 Medtronic Major Business
- 2.3.3 Medtronic Non-Invasive Blood Glucose Monitoring Devices Product and Services
- 2.3.4 Medtronic Non-Invasive Blood Glucose Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Medtronic Recent Developments/Updates
- 2.4 Dexcom
- 2.4.1 Dexcom Details
- 2.4.2 Dexcom Major Business
- 2.4.3 Dexcom Non-Invasive Blood Glucose Monitoring Devices Product and Services
- 2.4.4 Dexcom Non-Invasive Blood Glucose Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Dexcom Recent Developments/Updates
- 2.5 I-SENS
- 2.5.1 I-SENS Details
- 2.5.2 I-SENS Major Business
- 2.5.3 I-SENS Non-Invasive Blood Glucose Monitoring Devices Product and Services
- 2.5.4 I-SENS Non-Invasive Blood Glucose Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 I-SENS Recent Developments/Updates
- 2.6 Senseonics
- 2.6.1 Senseonics Details
- 2.6.2 Senseonics Major Business
- 2.6.3 Senseonics Non-Invasive Blood Glucose Monitoring Devices Product and Services
- 2.6.4 Senseonics Non-Invasive Blood Glucose Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Senseonics Recent Developments/Updates
- 2.7 Yuwell
- 2.7.1 Yuwell Details
- 2.7.2 Yuwell Major Business
- 2.7.3 Yuwell Non-Invasive Blood Glucose Monitoring Devices Product and Services
- 2.7.4 Yuwell Non-Invasive Blood Glucose Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Yuwell Recent Developments/Updates
- 2.8 Sinocare
- 2.8.1 Sinocare Details
- 2.8.2 Sinocare Major Business
- 2.8.3 Sinocare Non-Invasive Blood Glucose Monitoring Devices Product and Services
- 2.8.4 Sinocare Non-Invasive Blood Glucose Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Sinocare Recent Developments/Updates
- 2.9 MicroTech Medical
- 2.9.1 MicroTech Medical Details
- 2.9.2 MicroTech Medical Major Business
- 2.9.3 MicroTech Medical Non-Invasive Blood Glucose Monitoring Devices Product and Services
- 2.9.4 MicroTech Medical Non-Invasive Blood Glucose Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 MicroTech Medical Recent Developments/Updates
- 2.10 POCTech
- 2.10.1 POCTech Details
- 2.10.2 POCTech Major Business
- 2.10.3 POCTech Non-Invasive Blood Glucose Monitoring Devices Product and Services
- 2.10.4 POCTech Non-Invasive Blood Glucose Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 POCTech Recent Developments/Updates
- 2.11 Medtrum Technologies
- 2.11.1 Medtrum Technologies Details
- 2.11.2 Medtrum Technologies Major Business
- 2.11.3 Medtrum Technologies Non-Invasive Blood Glucose Monitoring Devices Product and Services
- 2.11.4 Medtrum Technologies Non-Invasive Blood Glucose Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Medtrum Technologies Recent Developments/Updates
- 2.12 SIBIONICS
- 2.12.1 SIBIONICS Details
- 2.12.2 SIBIONICS Major Business
- 2.12.3 SIBIONICS Non-Invasive Blood Glucose Monitoring Devices Product and Services
- 2.12.4 SIBIONICS Non-Invasive Blood Glucose Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 SIBIONICS Recent Developments/Updates
3 Competitive Environment: Non-Invasive Blood Glucose Monitoring Devices by Manufacturer
- 3.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Manufacturer (2021-2026)
- 3.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Non-Invasive Blood Glucose Monitoring Devices by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Non-Invasive Blood Glucose Monitoring Devices Manufacturer Market Share in 2025
- 3.4.3 Top 6 Non-Invasive Blood Glucose Monitoring Devices Manufacturer Market Share in 2025
- 3.5 Non-Invasive Blood Glucose Monitoring Devices Market: Overall Company Footprint Analysis
- 3.5.1 Non-Invasive Blood Glucose Monitoring Devices Market: Region Footprint
- 3.5.2 Non-Invasive Blood Glucose Monitoring Devices Market: Company Product Type Footprint
- 3.5.3 Non-Invasive Blood Glucose Monitoring Devices Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size by Region
- 4.1.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Region (2021-2032)
- 4.1.2 Global Non-Invasive Blood Glucose Monitoring Devices Consumption Value by Region (2021-2032)
- 4.1.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Price by Region (2021-2032)
- 4.2 North America Non-Invasive Blood Glucose Monitoring Devices Consumption Value (2021-2032)
- 4.3 Europe Non-Invasive Blood Glucose Monitoring Devices Consumption Value (2021-2032)
- 4.4 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Consumption Value (2021-2032)
- 4.5 South America Non-Invasive Blood Glucose Monitoring Devices Consumption Value (2021-2032)
- 4.6 Middle East & Africa Non-Invasive Blood Glucose Monitoring Devices Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Type (2021-2032)
- 5.2 Global Non-Invasive Blood Glucose Monitoring Devices Consumption Value by Type (2021-2032)
- 5.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Application (2021-2032)
- 6.2 Global Non-Invasive Blood Glucose Monitoring Devices Consumption Value by Application (2021-2032)
- 6.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Price by Application (2021-2032)
7 North America
- 7.1 North America Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Type (2021-2032)
- 7.2 North America Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Application (2021-2032)
- 7.3 North America Non-Invasive Blood Glucose Monitoring Devices Market Size by Country
- 7.3.1 North America Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Country (2021-2032)
- 7.3.2 North America Non-Invasive Blood Glucose Monitoring Devices Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Type (2021-2032)
- 8.2 Europe Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Application (2021-2032)
- 8.3 Europe Non-Invasive Blood Glucose Monitoring Devices Market Size by Country
- 8.3.1 Europe Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Non-Invasive Blood Glucose Monitoring Devices Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Market Size by Region
- 9.3.1 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Type (2021-2032)
- 10.2 South America Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Application (2021-2032)
- 10.3 South America Non-Invasive Blood Glucose Monitoring Devices Market Size by Country
- 10.3.1 South America Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Country (2021-2032)
- 10.3.2 South America Non-Invasive Blood Glucose Monitoring Devices Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Non-Invasive Blood Glucose Monitoring Devices Market Size by Country
- 11.3.1 Middle East & Africa Non-Invasive Blood Glucose Monitoring Devices Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Non-Invasive Blood Glucose Monitoring Devices Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Non-Invasive Blood Glucose Monitoring Devices Market Drivers
- 12.2 Non-Invasive Blood Glucose Monitoring Devices Market Restraints
- 12.3 Non-Invasive Blood Glucose Monitoring Devices Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Non-Invasive Blood Glucose Monitoring Devices and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Non-Invasive Blood Glucose Monitoring Devices
- 13.3 Non-Invasive Blood Glucose Monitoring Devices Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Non-Invasive Blood Glucose Monitoring Devices Typical Distributors
- 14.3 Non-Invasive Blood Glucose Monitoring Devices Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Non-Invasive Blood Glucose Monitoring Devices. Industry analysis & Market Report on Non-Invasive Blood Glucose Monitoring Devices is a syndicated market report, published as Global Non-Invasive Blood Glucose Monitoring Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Non-Invasive Blood Glucose Monitoring Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
